UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000032585
Receipt number R000037039
Scientific Title Phase II study of atezolizumab for advanced non-small-cell lung cancer patients not indicative of cytotoxic chemotherapy
Date of disclosure of the study information 2018/07/01
Last modified on 2022/05/18 22:03:28

No. Disposal Last modified on Item of update
1 Insert 2018/05/14 13:39:47
2 Update 2018/06/25 21:05:07 Recruitment status
Date of protocol fixation
Anticipated trial start date
3 Update 2019/03/22 12:05:56 Date of IRB
Last follow-up date
4 Update 2019/03/22 12:07:36 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
5 Update 2022/05/18 22:03:28 Recruitment status